查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786980

紅生物科技的全球市場，規模，佔有率，趨勢，產業分析報告:各產品，各最終用途，各地區 - 市場預測(2025年～2034年)

Red Biotechnology Market Size, Share, Trends, Industry Analysis Report By Product (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Proteins, Vaccines, Cell-Based Immunotherapy Products), By End Use, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，全球紅色生物技術市場規模將達到 14,157.7 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

紅色生物技術是生物技術的一個分支，專注於改善人類健康的醫療和製藥應用。它利用生物體、細胞和生物過程來開發治療、診斷和疾病預防方法。該領域為複雜的健康挑戰提供創新解決方案，並在現代醫學的發展中發揮關鍵作用。

紅色生物技術的主要應用之一是藥物開發。研究人員正在利用基因工程生產胰島素、疫苗和單株抗體等生物製藥。重組 DNA 技術使得利用基因改造細菌生產人類胰島素成為可能。同樣，mRNA疫苗和療法（例如為COVID-19開發的疫苗和療法）表明，紅色生物技術能夠快速應對疫情。

紅色生物技術還能增強診斷工具和技術。聚合酶鍊式反應 (PCR) 和新一代定序 (NGS) 等先進技術能夠及早、準確地檢測癌症和傳染病等疾病。此外，紅色生物技術支持疫苗的開發，以預防B肝、HPV和流感等疾病。合成生物學加速了疫苗設計，生物反應器促進了疫苗的大規模生產。在癌症治療領域，紅色生物技術的創新免疫療法利用免疫系統來靶向腫瘤，CAR-T細胞等療法已在某些血癌治療中取得顯著成功。

紅色生物技術市場報告重點

按產品類型劃分，廣泛用於治療癌症、自體免疫疾病和傳染病的單株抗體預計將在2024年佔市場收入的49.13%。

按最終用途劃分，製藥和生物技術公司在推動生物製劑和先進療法的創新、臨床開發和商業化方面發揮了重要作用，在2024年佔了相當大的收入佔有率。

2024年，北美佔了全球紅色生物技術市場的34.16%。這種主導地位歸因於完善的醫療基礎設施、高額的研發投入以及癌症、糖尿病和心血管疾病等慢性疾病的日益普及。

得益於全民健保體系、政府和歐盟的大力資助以及對再生醫學和生物相似藥的重視，預計到2034年，歐洲市場將佔相當大的佔有率。

受醫療支出成長、中產階級壯大以及傳染性和非傳染性疾病負擔加重的推動，亞太市場預計在2025年至2034年間的複合年增長率將達到15.34%。

紅色生物技術市場的全球領導公司包括安進、阿斯特捷利康、百健、百時美施貴寶、羅氏製藥、吉利德科學、默克、Mavrix Bio、輝瑞、再生元和武田製藥。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球紅生物科技市場洞察

  • 市場概述
  • 紅生物科技市場動態
    • 促進因素和機會
      • 個人化醫療需求不斷成長
      • 癌症研究投資不斷增加
    • 限制因素與挑戰
      • 成本高昂
  • PESTEL分析
  • 紅生物科技市場趨勢
  • 價值鏈分析

第5章 全球紅生物科技市場:各產品

  • 主要調查結果
  • 簡介
  • 單株抗體
  • 多株抗體
  • 重組蛋白品質
  • 疫苗
  • 細胞為基礎的免疫療法產品
  • 基因治療產品
  • 細胞治療產品
  • 組織工程產品
  • 幹細胞
  • 細胞培養
  • 病毒載體
  • 酵素
  • 套件和試劑
  • 動物模式
  • 分子診斷
  • 其他

第6章 全球紅生物科技市場:各最終用途

  • 主要調查結果
  • 簡介
  • 學術研究機關
  • CMO和CRO
  • 製藥·生物科技企業
  • 其他

第7章 全球紅生物科技市場:各地區

  • 主要調查結果
  • 簡介
    • 紅生物科技市場評估:各地區，2020～2034年
  • 北美
    • 北美:各產品，2020～2034年
    • 北美:各最終用途，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各產品，2020～2034年
    • 歐洲:各最終用途，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各產品，2020～2034年
    • 亞太地區:各最終用途，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各產品，2020～2034年
    • 中東·非洲:各最終用途，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各產品，2020～2034年
    • 南美:各最終用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第8章 競爭情形

  • 事業擴大·收購分析
    • 事業擴大
    • 收購
  • 聯盟/合作/協定/公開

第9章 企業簡介

  • AstraZeneca
  • Amgen Inc.
  • Merck & Co
  • Bristol-Myers Squibb
  • Pfizer
  • Biogen
  • F. Hoffmann-La Roche Ltd
  • Gilead Sciences, Inc.
  • MavriX Bio
  • Regeneron Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company
Product Code: PM5961

The red biotechnology market size is expected to reach USD 1,415.77 billion by 2034, according to a new study by Polaris Market Research. The report "Red Biotechnology Market Size, Share, Trends, Industry Analysis Report By Product (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Proteins, Vaccines, Cell-Based Immunotherapy Products), By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Red biotechnology, a branch of biotechnology, focuses on medical and pharmaceutical applications to improve human health. It involves the use of living organisms, cells, and biological processes to develop therapies, diagnostics, and preventive measures for diseases. This field plays a crucial role in advancing modern medicine, offering innovative solutions for complex health challenges.

One of the primary applications of red biotechnology is in the development of drugs. Researchers produce biopharmaceuticals such as insulin, vaccines, and monoclonal antibodies by leveraging genetic engineering. Recombinant DNA technology enables the production of human insulin using genetically modified bacteria. Similarly, mRNA vaccines and therapeutics, such as those developed for COVID-19, demonstrate how red biotechnology enables rapid responses to pandemics.

Red biotechnology also enhances diagnostic tools and techniques. Advanced techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), enable the early and accurate detection of diseases, including cancers and infectious diseases. Furthermore, red biotechnology supports vaccine development, which prevents diseases such as hepatitis B, HPV, and influenza. Synthetic biology accelerates vaccine design, while bioreactors facilitate large-scale production. In cancer treatment, immunotherapy, a red biotechnology innovation, harnesses the immune system to target tumors, with therapies such as CAR-T cells showing remarkable success in certain blood cancers.

Red Biotechnology Market Report Highlights

In terms of product, the monoclonal antibodies segment accounted for 49.13% of market revenue share in 2024 due to their widespread adoption in the treatment of cancer, autoimmune disorders, and infectious diseases.

Based on end use, the pharmaceutical & biotechnology companies segment accounted for a major revenue share in 2024 due to their role in driving innovation, clinical development, and commercialization of biologics and advanced therapies.

North America accounted for a 34.16% share of the global red biotechnology market in 2024. This dominance is attributed to established healthcare infrastructure, high R&D investments, and a growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders.

The market in Europe is projected to hold a substantial share by 2034 due to universal healthcare systems, strong government and EU funding, and a focus on regenerative medicine and biosimilars.

The market in Asia Pacific is projected to register a CAGR of 15.34% from 2025 to 2034, owing to increasing healthcare spending, a rising middle class, and a high burden of infectious and noncommunicable diseases.

A few global key players in the red biotechnology market include Amgen Inc.; AstraZeneca; Biogen; Bristol-Myers Squibb Company; F. Hoffmann-La Roche Ltd; Gilead Sciences, Inc.; Merck KGaA; MavriX Bio; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; and Takeda Pharmaceutical Company Limited.

Polaris Market Research has segmented the red biotechnology market report on the basis of product, end use, and region:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Monoclonal Antibodies

Polyclonal Antibodies

Recombinant Proteins

Vaccines

Cell-Based Immunotherapy Products

Gene Therapy Products

Cell Therapy Products

Tissue-Engineered Products

Stem Cells

Cell Culture

Viral Vector

Enzymes

Kits and Reagents

Animal Models

Molecular Diagnostics

Other

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Academic Research Institutes

CMOs & CROs

Pharmaceutical & Biotechnology Companies

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Red Biotechnology Market Insights

  • 4.1. Red Biotechnology Market - Market Snapshot
  • 4.2. Red Biotechnology Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Demand for Personalized Medicine
      • 4.2.1.2. Rising Investment in Cancer Research
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Red Biotechnology Market Trends
  • 4.6. Value Chain Analysis

5. Global Red Biotechnology Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Monoclonal Antibodies
    • 5.3.1. Global Red Biotechnology Market, by Monoclonal Antibodies, by Region, 2020-2034 (USD Billion)
  • 5.4. Polyclonal Antibodies
    • 5.4.1. Global Red Biotechnology Market, by Polyclonal Antibodies, by Region, 2020-2034 (USD Billion)
  • 5.5. Recombinant Proteins
    • 5.5.1. Global Red Biotechnology Market, by Recombinant Proteins, by Region, 2020-2034 (USD Billion)
  • 5.6. Vaccines
    • 5.6.1. Global Red Biotechnology Market, by Vaccines, by Region, 2020-2034 (USD Billion)
  • 5.7. Cell-Based Immunotherapy Products
    • 5.7.1. Global Red Biotechnology Market, by Cell-Based Immunotherapy Products, by Region, 2020-2034 (USD Billion)
  • 5.8. Gene Therapy Products
    • 5.8.1. Global Red Biotechnology Market, by Gene Therapy Products, by Region, 2020-2034 (USD Billion)
  • 5.9. Cell Therapy Products
    • 5.9.1. Global Red Biotechnology Market, by Cell Therapy Products, by Region, 2020-2034 (USD Billion)
  • 5.10. Tissue-Engineered Products
    • 5.10.1. Global Red Biotechnology Market, by Tissue-Engineered Products, by Region, 2020-2034 (USD Billion)
  • 5.11. Stem Cells
    • 5.11.1. Global Red Biotechnology Market, by Stem Cells, by Region, 2020-2034 (USD Billion)
  • 5.12. Cell Culture
    • 5.12.1. Global Red Biotechnology Market, by Cell Culture, by Region, 2020-2034 (USD Billion)
  • 5.13. Viral Vector
    • 5.13.1. Global Red Biotechnology Market, by Viral Vector, by Region, 2020-2034 (USD Billion)
  • 5.14. Enzymes
    • 5.14.1. Global Red Biotechnology Market, by Enzymes, by Region, 2020-2034 (USD Billion)
  • 5.15. Kits and Reagents
    • 5.15.1. Global Red Biotechnology Market, by Kits and Reagents, by Region, 2020-2034 (USD Billion)
  • 5.16. Animal Models
    • 5.16.1. Global Red Biotechnology Market, by Animal Models, by Region, 2020-2034 (USD Billion)
  • 5.17. Molecular Diagnostics
    • 5.17.1. Global Red Biotechnology Market, by Molecular Diagnostics, by Region, 2020-2034 (USD Billion)
  • 5.18. Others
    • 5.18.1. Global Red Biotechnology Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Red Biotechnology Market, by End Use

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • 6.3. Academic Research Institutes
    • 6.3.1. Global Red Biotechnology Market, by Academic Research Institutes, by Region, 2020-2034 (USD Billion)
  • 6.4. CMOs & CROs
    • 6.4.1. Global Red Biotechnology Market, by CMOs & CROs, by Region, 2020-2034 (USD Billion)
  • 6.5. Pharmaceutical & Biotechnology Companies
    • 6.5.1. Global Red Biotechnology Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
  • 6.6. Others
    • 6.6.1. Global Red Biotechnology Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Red Biotechnology Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Red Biotechnology Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Red Biotechnology Market - North America
    • 7.3.1. North America: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
    • 7.3.2. North America: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.3. Red Biotechnology Market - U.S.
      • 7.3.3.1. U.S.: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.3.4. Red Biotechnology Market - Canada
      • 7.3.4.1. Canada: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • 7.4. Red Biotechnology Market - Europe
    • 7.4.1. Europe: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.3. Red Biotechnology Market - UK
      • 7.4.3.1. UK: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.4. Red Biotechnology Market - France
      • 7.4.4.1. France: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.5. Red Biotechnology Market - Germany
      • 7.4.5.1. Germany: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.6. Red Biotechnology Market - Italy
      • 7.4.6.1. Italy: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.7. Red Biotechnology Market - Spain
      • 7.4.7.1. Spain: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.8. Red Biotechnology Market - Netherlands
      • 7.4.8.1. Netherlands: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.9. Red Biotechnology Market - Russia
      • 7.4.9.1. Russia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.4.10. Red Biotechnology Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • 7.5. Red Biotechnology Market - Asia Pacific
    • 7.5.1. Asia Pacific: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.3. Red Biotechnology Market - China
      • 7.5.3.1. China: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.4. Red Biotechnology Market - India
      • 7.5.4.1. India: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.5. Red Biotechnology Market - Malaysia
      • 7.5.5.1. Malaysia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.6. Red Biotechnology Market - Japan
      • 7.5.6.1. Japan: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.7. Red Biotechnology Market - Indonesia
      • 7.5.7.1. Indonesia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.8. Red Biotechnology Market - South Korea
      • 7.5.8.1. South Korea: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.9. Red Biotechnology Market - Australia
      • 7.5.9.1. Australia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.5.10. Red Biotechnology Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • 7.6. Red Biotechnology Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.3. Red Biotechnology Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.4. Red Biotechnology Market - UAE
      • 7.6.4.1. UAE: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.5. Red Biotechnology Market - Israel
      • 7.6.5.1. Israel: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.6. Red Biotechnology Market - South Africa
      • 7.6.6.1. South Africa: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.6.7. Red Biotechnology Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • 7.7. Red Biotechnology Market - Latin America
    • 7.7.1. Latin America: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.3. Red Biotechnology Market - Mexico
      • 7.7.3.1. Mexico: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.4. Red Biotechnology Market - Brazil
      • 7.7.4.1. Brazil: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.5. Red Biotechnology Market - Argentina
      • 7.7.5.1. Argentina: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
    • 7.7.6. Red Biotechnology Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. AstraZeneca
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Amgen Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Merck & Co
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Bristol-Myers Squibb
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Pfizer
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Biogen
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. F. Hoffmann-La Roche Ltd
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Gilead Sciences, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. MavriX Bio
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Regeneron Pharmaceuticals, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Takeda Pharmaceutical Company
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development

List of Tables:

  • Table 1 Global Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 3 North America: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 4 North America: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 5 U.S.: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 6 U.S.: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 7 Canada: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 8 Canada: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 9 Europe: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 10 Europe: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 11 UK: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 12 UK: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 13 France: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 14 France: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 15 Germany: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 16 Germany: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 17 Italy: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 18 Italy: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 19 Spain: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 20 Spain: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 23 Russia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 24 Russia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 29 China: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 30 China: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 31 India: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 32 India: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 35 Japan: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 36 Japan: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 39 South Korea: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 40 South Korea: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 41 Australia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 42 Australia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 49 UAE: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 50 UAE: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 51 Israel: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 52 Israel: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 53 South Africa: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 54 South Africa: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 57 Latin America: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 58 Latin America: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 59 Mexico: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 60 Mexico: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 61 Brazil: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Brazil: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 63 Argentina: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 64 Argentina: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Red Biotechnology Market, by Product, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Red Biotechnology Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Red Biotechnology Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Red Biotechnology Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by End Use
  • Figure 9. Global Red Biotechnology Market, by End Use, 2024 & 2034 (USD Billion)